OMDA
Omada Health, Inc.
15.24
+0.18 (+1.20%)
52w low 10.28
25.45 high
32.7% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 89.19M | 122.78M | 169.80M | 260.21M | |
| Cost of Revenue | 46.39M | 52.81M | 66.92M | 89.27M | |
| Gross Profit | 42.79M | 69.97M | 102.88M | 170.94M | |
| Operating Expenses | 115.14M | 135.97M | 146.53M | 182.91M | |
| R&D | 26.17M | 33.74M | 35.92M | 40.68M | |
| SG&A | 88.97M | 102.23M | 110.61M | 142.23M | |
| Operating Income | -72.35M | -66.00M | -43.65M | -11.97M | |
| EBITDA | -63.99M | -58.36M | -37.83M | -4.75M | |
| Pretax Income | -72.52M | -67.51M | -47.14M | -12.78M | |
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -72.52M | -67.51M | -47.14M | -12.78M | |
| EPS Diluted | -1.52 | -1.41 | -0.85 | -0.35 | |
| Diluted Shares | 47.72M | 47.72M | 55.74M | 36.64M |
Revenue CAGR
+42.9%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+53.2%